Efficacy of adjunctive Celecoxib in improvement of Obsessive-compulsive disorder

Vice chancellor for research of Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Patients were considered for participation in the project if they were met DSM-1V criteria for diagnosis of OCD. The diagnosis was confirmed by a psychiatrist based on structured interview ; A minimum score of 21 or above on the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS).
•The patients did not receive any Psychotropic medications such as selective serotonin reuptake inhibitors (SSRIs), tricyclic Antidepressants (TCAs), or monoamine oxide inhibitors for 4 weeks preceding entry into the trial Patients; they suffered from known autoimmune disease; bipolar I or bipolar II disorder; eating disorders; personality disorders; mental retardation; substance dependence or abuse; had a concurrent medical illness; history of seizures that would contraindicate use of the study medication; receiving ECT; peptic ulcers or a history of gastrointestinal bleeding; use of any medications identified as contra-indicated with COX-2 inhibitors.

发起方

Vice chancellor for research of Mashhad University of Medical Sciences